Loading clinical trials...

Bevacizumab (Avastin) in Unresectable/Recurrent Hemangioblastoma From Von-Hippel-Lindau Disease | Clinical Trials | Clareo Health

Back to clinical trial search

TERMINATEDEARLY Phase 1NCT01015300

Bevacizumab (Avastin) in Unresectable/Recurrent Hemangioblastoma From Von-Hippel-Lindau Disease

Von Hippel-Lindau (VHL) disease is an inherited syndrome manifested by a variety of benign and malignant tumors. Hemangioblastomas are the most common lesion associated with VHL disease affecting 60-8...

Lead sponsor: Dartmouth-Hitchcock Medical Center•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITING

Data Collection Protocol for Patients With Von Hippel Lindau Disease

NCT05955014 · Von Hippel Lindau Disease

TERMINATED

Von Hippel-Lindau Disease Genetic Epidemiology Study

NCT00001803 · Von Hippel Lindau Disease, Kidney Neoplasms

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 11, 2012Terms

Trial snapshot

StatusTERMINATED

PhaseEARLY_PHASE1

Enrollment1

Start dateDec 2009

Last updatedMay 11, 2012

Condition

Hemangioblastomas Von Hippel Lindau Disease

Locations shown

Dartmouth Hitchcock Medical Center

Lebanon, New Hampshire

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 11, 2012Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions